GUNN, HAROLD DAVID,MULLINS, DAVID W.,BAZETT, MARK,KALYAN, SHIRIN
申请号:
CA3086832
公开号:
CA3086832A1
申请日:
2018.12.28
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
Therapeutic modalities are provided for targeting adoptive cellular therapies to specific sites of disease, involving the use of specific repertoirs of PRR ligands. In effect, innate immune system signaling is provoked so as to facilitate the homing of adoptive immune cells to sites of disease, for example to the site of a solid tumor.